- Home
- Products
Leqvio (Inclisiran)
Leqvio (Inclisiran)
- Medicine Name: Leqvio
- Generic Name: Inclisiran
- Dosage Form & Strength: Injection – 284 mg/1.5 mL (189 mg/mL) in a single-dose prefilled syringe
- Manufactured By: Novartis Pharmaceuticals Corporation
Leqvio is a SIRNA-based cholesterol-lowering medication used for adults with:
- Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia)
- Mixed dyslipidemia with inadequate response to statins
- Statin intolerance where alternative therapies are required
Leqvio works by inhibiting PCSK9 production, helping the liver remove more LDL-C (“bad cholesterol”) from the blood.
Recommended Dosage:
- 284 mg administered via subcutaneous injection
- Initial dose, then again at 3 months, and subsequently every 6 months
- Inject in upper arm, abdomen, or thigh
- Continue cholesterol-lowering diet and statin therapy as advised
If a dose is missed:
- Administer immediately if within 3 months of the scheduled date
- If delayed >3 months, restart: dose now, at 3 months, then every 6 months
Dialysis Consideration: Avoid hemodialysis within 72 hours of dosing
Pregnancy: Use with caution; limited data available. Avoid during pregnancy
Breastfeeding: Not recommended due to potential drug presence in breast milk
Injection Site: Avoid inflamed or damaged skin when administering
Leqvio has no known effect on the ability to drive or operate machinery.
To import Leqvio to India, you’ll need:
- Valid prescription from a certified physician
- Relevant diagnostic reports
- Government-issued patient ID
Availability:
Leqvio is available in India via Named Patient Import through Global Rare Meds. Serviceable cities include Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Ahmedabad, Pune, and more.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds sources Leqvio (Inclisiran) from certified global suppliers in the USA, Europe, Canada, and Australia. Fulfillment is through our licensed distribution center in Ambernath, Thane District.
We ensure:
- Compliance with Indian regulations
- Pharmacist-verified prescriptions
- Secure cold chain shipping
- Nationwide delivery
Q: What is the generic name of Leqvio®?
A: Inclisiran
Q: Who manufactures Leqvio®?
A: Novartis Pharmaceuticals Corporation
Q: What is Leqvio used for?
A: Lowering LDL cholesterol in adults with high cholesterol or mixed dyslipidemia
Q: Is Leqvio® FDA-approved?
A: Yes, approved on December 22, 2021
Q: What is the dosage form of Leqvio®?
A: 284 mg/1.5 mL prefilled syringe for subcutaneous use
Q: How is Leqvio administered?
A: By a healthcare provider under the skin – initial dose, then at 3 months, and every 6 months thereafter
Q: What are common side effects?
A:
- Injection site reactions
- Joint pain
- Diarrhea
- Urinary tract infections
- Bronchitis
- Pain in the limbs
- Shortness of breath
Q: How should Leqvio be stored?
A: Store at 20-25°C (68-77°F). Excursions allowed between 15-30°C (59-86°F)
Q: Is it safe to buy Leqvio online from India?
A: Yes, Global Rare Meds ensures safe and legal import of Leqvio via proper documentation and verified sourcing.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
